Breakthrough research reveals how to target malignant DNA in aggressive cancers

Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments.

Agios drug reduces blood transfusions in patients with beta-thalassemia, study shows

Agios Pharmaceuticals said Monday that its drug called mitapivat reduced the need for blood transfusions in patients with a severe form of beta-thalassemia, an inherited

June 3, 2024

PSMA PET Beats MRI in Prostate Cancer Staging Study

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II

July 3, 2024

Yet Another Injectable Combo Achieves Near 15% Weight Loss in Trial

SAN DIEGO — Another investigational treatment containing a GLP-1 receptor agonist induced major weight loss in people with obesity in a phase II study, though

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.